
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CPRX · as of Jun 8, 2026
Key Statistics
Explore Catalyst Pharmaceuticals, Inc. Data
cprx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 75.0%
The CPRX analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $31.75, representing +1.54% upside from the current price of $31.27.
Competitors & Peers
cprx competitorsStock Performance
Full HistoryAbout Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurolog…
what is catalyst pharmaceuticals, inc. · cprx stock overview · catalyst pharmaceuticals, inc. company profile · who is catalyst pharmaceuticals, inc. ceo · cprx NASDAQ · catalyst pharmaceuticals, inc. headquarters · catalyst pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Catalyst Pharmaceuticals, Inc. (CPRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 8, 2006. As of the latest trading session, CPRX stock price is $31.27, with a market capitalization of $3.8B. The stock has returned +21.01% over the past 12 months and +33.98% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Catalyst Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $31.75. In fiscal year 2025, Catalyst Pharmaceuticals, Inc. reported revenue of $589.0M and net income of $214.3M. For detailed data — including Catalyst Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Catalyst Pharmaceuticals, Inc. (CPRX) stock price is $31.27. The stock is traded on NASDAQ under the ticker symbol CPRX. The 52-week range is $19.05 – $32.56.